According to clinical trial data from the STEP trials, 43.9% of patients taking semaglutide 2.4 mg experienced nausea at some point during treatment, with the majority of episodes occurring during or immediately after dose increases
The roughly six-day half-life means levels stay relatively steady between doses, avoiding the sharp swings that can make some compounds feel uneven
Clinical Experience From members of the Microdose program

Marek focuses on hormone optimization with lab-driven protocols and partner clinicians - Marek is generally more expensive and expects lab testing - Not a direct substitute for a weight-loss-only GLP-1 subscription - See Marek Health reviews Pomegranate Health vs LillyDirect or Novo self-pay: - LillyDirect sells Zepbound to self-pay patients at ~$350-$550/month for FDA-approved product - Novo self-pay options for Wegovy and Ozempic are more limited but expanding - Brand products have published stability, standardized manufacturing, and no compounding regulatory question - Increasingly the default for patients without insurance coverage - See where to buy tirzepatide Pomegranate Health vs a local compounding pharmacy: - Bypasses the telehealth middleman and subscription layer - Requires you to find a PCAB-accredited local compounding pharmacy that can serve you - Usually cheaper per month once the setup is complete, but requires more self-advocacy and often an in-person prescriber - Not practical for patients without a clinician willing to write the prescription The rule of thumb: for most patients, if insurance covers brand GLP-1 use the brand

Presented for research literature review only Karasu-Minareci E et al
let the water slide down and reconstitute the powder through passive diffusion